- Rhabdomyolysis in a patient taking nebivolol
-
Kim YJ, Kim HR, Jeon HJ, Ju HJ, Chung S, Choi DE, Lee KW, Na KR
- KMID: 2353462
- Kidney Res Clin Pract.
- 2016 Sep;35(3):182-186.
- doi: 10.1016/j.krcp.2015.09.003
β Blockers such as propranolol and labetalol are known to induce toxic myopathy because of their partial β₂ adrenoceptor agonistic effect. Nebivolol has the highest β1 receptor affinity among β... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Beta Blockers in Treating Hypertensive Patients
-
Lim SY
- KMID: 2172264
- Chonnam Med J.
- 2009 Aug;45(2):75-78.
- doi: 10.4068/cmj.2009.45.2.75
Beta-blockers have been used to treat hypertension for many years. Although beta-blockers can lower blood pressure, current data concerning the efficacy of these drugs have been disappointing, and the value... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Low-Dose Nebivolol in Patients with Acute Myocardial Infarction: A Multi-Center Observational Study
-
Sim DS, Hyun DY, Jeong MH, Kim HS, Chang K, Choi DJ, Han KR, Ahn TH, Bae JH, Choi SW, Park JS, Hur SH, Chae JK, Oh SK, Cha KS, Hwang JY
- KMID: 2468147
- Chonnam Med J.
- 2020 Jan;56(1):55-61.
- doi: 10.4068/cmj.2020.56.1.55
The optimal dose of beta blockers after acute myocardial infarction (MI) remains uncertain. We evaluated the effectiveness of low-dose nebivolol, a beta1 blocker and a vasodilator, in patients with acute... -
- CITED
-
- Close
- SHARE
-
- Close
- Update on Newer Antihypertensive Medicines
-
Park CG
- KMID: 2188348
- J Korean Med Assoc.
- 2010 Aug;53(8):717-722.
- doi: 10.5124/jkma.2010.53.8.717
The majority of hypertensive patients do not achieve target blood pressure for a variety of reasons, including insufficient medication, drug resistance, and noncompliance. There remains a significant need to develop... -
- CITED
-
- Close
- SHARE
-
- Close
